ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/06 | 3,185 | 3,205 | 3,150 | 3,185 | +5 | +0.2% | 64,900 |
2023/02/03 | 3,230 | 3,230 | 3,125 | 3,180 | -55 | -1.7% | 113,300 |
2023/02/02 | 3,240 | 3,270 | 3,225 | 3,235 | -5 | -0.2% | 27,100 |
2023/02/01 | 3,240 | 3,295 | 3,220 | 3,240 | +15 | +0.5% | 32,900 |
2023/01/31 | 3,275 | 3,275 | 3,225 | 3,225 | -30 | -0.9% | 41,200 |
2023/01/30 | 3,250 | 3,310 | 3,210 | 3,255 | ±0 | ±0% | 55,900 |
2023/01/27 | 3,365 | 3,365 | 3,255 | 3,255 | -80 | -2.4% | 75,700 |
2023/01/26 | 3,340 | 3,375 | 3,305 | 3,335 | -10 | -0.3% | 51,400 |
2023/01/25 | 3,310 | 3,375 | 3,265 | 3,345 | +35 | +1.1% | 64,900 |
2023/01/24 | 3,345 | 3,360 | 3,305 | 3,310 | -35 | -1% | 48,600 |
2023/01/23 | 3,395 | 3,400 | 3,305 | 3,345 | -25 | -0.7% | 81,500 |
2023/01/20 | 3,330 | 3,400 | 3,330 | 3,370 | ±0 | ±0% | 43,000 |
2023/01/19 | 3,390 | 3,390 | 3,330 | 3,370 | -60 | -1.7% | 82,900 |
2023/01/18 | 3,460 | 3,460 | 3,370 | 3,430 | -35 | -1% | 63,600 |
2023/01/17 | 3,545 | 3,545 | 3,455 | 3,465 | -10 | -0.3% | 46,700 |
2023/01/16 | 3,515 | 3,590 | 3,450 | 3,475 | +50 | +1.5% | 107,200 |
2023/01/13 | 3,440 | 3,455 | 3,405 | 3,425 | -20 | -0.6% | 39,300 |
2023/01/12 | 3,440 | 3,495 | 3,420 | 3,445 | +45 | +1.3% | 69,100 |
2023/01/11 | 3,380 | 3,430 | 3,370 | 3,400 | +10 | +0.3% | 67,200 |
2023/01/10 | 3,460 | 3,480 | 3,375 | 3,390 | -35 | -1% | 61,500 |
2023/01/06 | 3,395 | 3,435 | 3,340 | 3,425 | +5 | +0.1% | 61,200 |
2023/01/05 | 3,435 | 3,470 | 3,360 | 3,420 | -25 | -0.7% | 100,500 |
2023/01/04 | 3,715 | 3,715 | 3,415 | 3,445 | -305 | -8.1% | 216,300 |
2022/12/30 | 3,665 | 3,775 | 3,620 | 3,750 | +125 | +3.4% | 108,900 |
2022/12/29 | 3,740 | 3,740 | 3,610 | 3,625 | -325 | -8.2% | 233,600 |
2022/12/28 | 4,090 | 4,100 | 3,945 | 3,950 | -120 | -2.9% | 182,200 |
2022/12/27 | 4,075 | 4,165 | 4,060 | 4,070 | +10 | +0.2% | 103,800 |
2022/12/26 | 4,095 | 4,100 | 3,960 | 4,060 | ±0 | ±0% | 121,800 |
2022/12/23 | 4,055 | 4,120 | 4,010 | 4,060 | +5 | +0.1% | 83,200 |
2022/12/22 | 4,105 | 4,105 | 3,975 | 4,055 | ±0 | ±0% | 90,900 |
2022/12/21 | 4,195 | 4,215 | 4,030 | 4,055 | -95 | -2.3% | 101,200 |
2022/12/20 | 4,250 | 4,275 | 4,090 | 4,150 | -40 | -1% | 126,600 |
2022/12/19 | 4,105 | 4,260 | 4,050 | 4,190 | +75 | +1.8% | 162,900 |
2022/12/16 | 4,035 | 4,155 | 4,005 | 4,115 | +60 | +1.5% | 100,500 |
2022/12/15 | 4,105 | 4,115 | 4,030 | 4,055 | -60 | -1.5% | 92,700 |
2022/12/14 | 4,135 | 4,135 | 4,075 | 4,115 | ±0 | ±0% | 73,700 |
2022/12/13 | 4,160 | 4,160 | 4,075 | 4,115 | -35 | -0.8% | 85,200 |
2022/12/12 | 4,000 | 4,205 | 4,000 | 4,150 | +115 | +2.9% | 220,700 |
2022/12/09 | 3,960 | 4,045 | 3,950 | 4,035 | +65 | +1.6% | 87,700 |
2022/12/08 | 3,935 | 4,010 | 3,920 | 3,970 | +35 | +0.9% | 90,000 |
2022/12/07 | 3,770 | 3,955 | 3,770 | 3,935 | +175 | +4.7% | 95,900 |
2022/12/06 | 3,715 | 3,765 | 3,670 | 3,760 | -10 | -0.3% | 66,400 |
2022/12/05 | 3,840 | 3,845 | 3,735 | 3,770 | -110 | -2.8% | 106,700 |
2022/12/02 | 3,885 | 3,925 | 3,840 | 3,880 | -10 | -0.3% | 69,300 |
2022/12/01 | 3,920 | 3,950 | 3,890 | 3,890 | -30 | -0.8% | 80,800 |
2022/11/30 | 3,915 | 3,970 | 3,890 | 3,920 | -30 | -0.8% | 62,900 |
2022/11/29 | 3,950 | 3,995 | 3,905 | 3,950 | +70 | +1.8% | 111,900 |
2022/11/28 | 4,050 | 4,065 | 3,840 | 3,880 | -170 | -4.2% | 237,200 |
2022/11/25 | 4,000 | 4,110 | 3,995 | 4,050 | +50 | +1.3% | 147,400 |
2022/11/24 | 4,040 | 4,070 | 3,905 | 4,000 | -30 | -0.7% | 192,400 |
451~
500
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 155,700円 | -5.1% | -21.2% | 5.14% | 9.83倍 | 1.88倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ハートシード | 148,300円 | +154.1% | - | 0.00% | - | 7.26倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ダイト | 212,700円 | +4.5% | -10.8% | 3.29% | 14.15倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
扶桑薬 | 253,600円 | +8.3% | +98.1% | 3.23% | 8.33倍 | 0.58倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
セルソース | 103,100円 | -3.0% | -55.9% | 0.48% | 48.98倍 | 3.38倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム